Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News SI-BONE Inc SIBN

SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants and... see more

Recent & Breaking News (NDAQ:SIBN)

SI-BONE To Report Third Quarter 2022 Financial Results on November 7, 2022

GlobeNewswire October 17, 2022

SI-BONE To Present at The Morgan Stanley 20th Annual Global Healthcare Conference

GlobeNewswire August 23, 2022

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2022

GlobeNewswire August 8, 2022

SI-BONE To Present at The Canaccord Genuity 42nd Annual Growth Conference 2022

GlobeNewswire July 18, 2022

SI-BONE To Report Second Quarter 2022 Financial Results on August 8, 2022

GlobeNewswire July 18, 2022

SI-BONE, Inc. Announces FDA Clearance for Expanded Indication of the iFuse-TORQ® Implant System

GlobeNewswire June 13, 2022

SI-BONE, Inc. Receives FDA 510(k) Clearance for iFuse Bedrock Granite, a Breakthrough Pelvic Fixation and Fusion Technology

GlobeNewswire May 31, 2022

SI-BONE, Inc. Reports First Quarter 2022 Financial Results

GlobeNewswire May 9, 2022

SI-BONE, Inc. Announces New Technology Add-On Payment for Breakthrough Adult Spinal Deformity Treatment

GlobeNewswire April 19, 2022

SI-BONE To Present at BofA Securities 2022 Healthcare Conference

GlobeNewswire April 18, 2022

SI-BONE To Report First Quarter 2022 Financial Results on May 9, 2022

GlobeNewswire April 18, 2022

SI-BONE, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Issues 2022 Revenue Guidance

GlobeNewswire February 28, 2022

SI-BONE To Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022

GlobeNewswire February 1, 2022

SI-BONE Announces Revenue for the Fourth Quarter and Full Year 2021

GlobeNewswire January 10, 2022

SI-BONE to participate in 24th Annual Needham Virtual Growth Conference

GlobeNewswire December 27, 2021

SI-BONE, Inc. Announces Updated Exclusive Blue Cross Blue Shield Association Evidence Street Opinion, and New Coverage Policies from Arkansas Blue Cross Blue Shield and Walmart Plans from BlueAdvantage Administrators of Arkansas

GlobeNewswire December 13, 2021

SI-BONE, Inc. Reports Third Quarter 2021 Financial Results and Updates 2021 Financial Guidance

GlobeNewswire November 8, 2021

SI-BONE To Report Third Quarter 2021 Financial Results on November 8, 2021

GlobeNewswire October 18, 2021

SI-BONE, Inc. Announces UnitedHealthcare Adopts Exclusive iFuse Only Coverage for Minimally Invasive SI Joint Fusion

GlobeNewswire October 11, 2021

SI-BONE to Participate in Upcoming Conferences

GlobeNewswire August 23, 2021